112 related articles for article (PubMed ID: 3617996)
21. [Clinical evaluation of intra-arterial infusion chemotherapy for advanced or recurrent pelvic tumors with or without radiotherapy].
Kaneyasu Y; Okawa MK; Kokubo N; Takemoto M; Karasawa K; Fukuhara N; Toda J; Okawa T
Gan To Kagaku Ryoho; 1996 Sep; 23(11):1486-93. PubMed ID: 8854787
[TBL] [Abstract][Full Text] [Related]
22. [Treatment outcome of children and adolescents with germ cell tumor after combined therapy---a report of 44 cases].
Sun XF; Yang QY; Zhen ZJ; Xia Y; Huang ZH; Ling JY
Ai Zheng; 2006 Dec; 25(12):1529-32. PubMed ID: 17166380
[TBL] [Abstract][Full Text] [Related]
23. Intratumoral microvessel density, response to chemotherapy and clinical outcome of patients with advanced ovarian carcinoma.
Gadducci A; Viacava P; Cosio S; Fanelli G; Fanucchi A; Cecchetti D; Cristofani R; Genazzani AR
Anticancer Res; 2003; 23(1B):549-56. PubMed ID: 12680144
[TBL] [Abstract][Full Text] [Related]
24. [A case of inflammatory breast cancer treated with preoperative intra-arterial infusion chemotherapy].
Migita T; Shiiba K; Saito Y; Shibata C; Matsuno S
Gan To Kagaku Ryoho; 1994 Dec; 21(16):2825-8. PubMed ID: 7993122
[TBL] [Abstract][Full Text] [Related]
25. Long-term survival in advanced ovarian cancer after cytoreduction and chemotherapy treatment.
Del Campo JM; Felip E; Rubio D; Vidal R; Bermejo B; Colomer R; Zanon V
Gynecol Oncol; 1994 Apr; 53(1):27-32. PubMed ID: 8175018
[TBL] [Abstract][Full Text] [Related]
26. [Surgical treatment of stage III-IV ovarian cancer].
Berishvili AI; Kuznetsov VV; Gorbunova VA; Bliumenberg AG
Vestn Khir Im I I Grek; 2002; 161(1):48-50. PubMed ID: 12048788
[TBL] [Abstract][Full Text] [Related]
27. [Selective arterial catheterization in the management of drug-resistant choriocarcinoma].
Yang X; Yang N; Song H
Zhonghua Fu Chan Ke Za Zhi; 1996 Apr; 31(4):199-202. PubMed ID: 8758771
[TBL] [Abstract][Full Text] [Related]
28. [Consecutive intra-arterial infusion of cis-diamminedichloroplatinum with continuous intra-arterial infusion of 5-fluorouracil in locally advanced ovarian cancer].
Shimizu Y; Fujiwara A; Akagaki E; Hirota K; Kono M; Irie T; Miura S; Okudaira Y
Gan To Kagaku Ryoho; 1986 May; 13(5):1934-9. PubMed ID: 3707153
[TBL] [Abstract][Full Text] [Related]
29. [Intra-arterial 5-FU/intra-venous MTX therapy for metastatic liver lesions].
Adachi S; Fukao K; Chikamori F; Yuzawa K; Shibuya S; Nozue M; Otsuka M; Ishikawa A; Todoroki T
Gan To Kagaku Ryoho; 1995 Sep; 22(11):1457-9. PubMed ID: 7574731
[TBL] [Abstract][Full Text] [Related]
30. Modulation of molecular marker expression by induction chemotherapy in locally advanced breast cancer: correlation with the response to therapy and the expression of MDR1 and LRP.
Schneider J; Lucas R; Sánchez J; Ruibal A; Tejerina A; Martín M
Anticancer Res; 2000; 20(6B):4373-7. PubMed ID: 11205274
[TBL] [Abstract][Full Text] [Related]
31. Second line platinum-based intraperitoneal chemotherapy for advanced ovarian cancer.
Milczek T; Klasa-Mazurkiewicz D; Emerich J; Kobierski J
Acta Obstet Gynecol Scand; 2009; 88(4):463-7. PubMed ID: 19235559
[TBL] [Abstract][Full Text] [Related]
32. Pure-type clear cell carcinoma of the ovary as a distinct histological type and improved survival in patients treated with paclitaxel-platinum-based chemotherapy in pure-type advanced disease.
Ho CM; Huang YJ; Chen TC; Huang SH; Liu FS; Chang Chien CC; Yu MH; Mao TL; Wang TY; Hsieh CY
Gynecol Oncol; 2004 Jul; 94(1):197-203. PubMed ID: 15262142
[TBL] [Abstract][Full Text] [Related]
33. Paclitaxel with carboplatin versus paclitaxel with carboplatin alternating with cisplatin as first-line chemotherapy in advanced epithelial ovarian cancer: preliminary results of a Hellenic Cooperative Oncology Group study.
Skarlos DV; Aravantinos G; Kosmidis P; Athanassiadis A; Stathopoulos GP; Pavlidis N; Bafaloukos D; Karphathios S; Papakostas P; Bamia C; Fountzilas G
Semin Oncol; 1997 Oct; 24(5 Suppl 15):S15-57-S15-61. PubMed ID: 9346224
[TBL] [Abstract][Full Text] [Related]
34. [Drug therapy of ovarian carcinoma].
Dittrich C
Wien Med Wochenschr; 1996; 146(1-2):23-34. PubMed ID: 8835492
[TBL] [Abstract][Full Text] [Related]
35. [Effect of low dose 5-fluorouracil and cisplatin intra-arterial infusion chemotherapy in advanced hepatocellular carcinoma with decompensated cirrhosis].
Lim TY; Cheong JY; Cho SW; Sim SJ; Kim JS; Choi SJ; Choi JW; Kwon HC; Lee KM; Kim JK; Won JH; Yoo BM; Lee KJ; Hahm KB; Kim JH
Korean J Hepatol; 2006 Mar; 12(1):65-73. PubMed ID: 16565607
[TBL] [Abstract][Full Text] [Related]
36. Chemotherapy of advanced ovarian cancer.
Martoni A; Cacciari N; Angelelli B; Zamagni C; Pannuti F
Front Biosci; 1997 Mar; 2():g20-6. PubMed ID: 9159262
[TBL] [Abstract][Full Text] [Related]
37. Management of ovarian endodermal sinus tumor.
Lian L; Huang H; Huang R; Lang J
Chin Med J (Engl); 1996 May; 109(5):344-8. PubMed ID: 9208488
[TBL] [Abstract][Full Text] [Related]
38. [Prognostic factors and better survival rate after the treatment of advanced ovarian cancer with neoadjuvant chemotherapy].
Ivanov S; Ivanov S; Khadzhiolov N
Akush Ginekol (Sofiia); 2004; 43(6):17-9. PubMed ID: 15669647
[TBL] [Abstract][Full Text] [Related]
39. [Adjuvant therapy of malignant ovarian tumors after organ preserving surgery].
Schröder W
Zentralbl Gynakol; 1996; 118(10):565-70. PubMed ID: 8912476
[TBL] [Abstract][Full Text] [Related]
40. [Characteristics of rare ovarian tumors--possibilities of organ preservation].
Grischke EM; Wallwiener D; Bastert G
Zentralbl Gynakol; 1996; 118(6):322-5. PubMed ID: 8768007
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
